ID

28922

Description

Impact of Atypical Antipsychotic Therapy on Health Outcomes and Costs Among Patients With Major Depressive Disorder; ODM derived from: https://clinicaltrials.gov/show/NCT01145313

Link

https://clinicaltrials.gov/show/NCT01145313

Keywords

Versions (1)
  1. 2/16/18 2/16/18 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

February 16, 2018

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Depressive Disorder, Major NCT01145313

English

Eligibility Depressive Disorder, Major NCT01145313

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients who meet the following criteria will be included in the study:
Description

Criteria Fulfill

Data type

boolean

Alias
UMLS CUI [1,1]
C0243161
UMLS CUI [1,2]
C1550543
aged 18 to 64 years
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
diagnosis of major depressive disorder during the study timeframe (icd 9 codes 296.2, 296.3, 311)
Description

Major Depressive Disorder

Data type

boolean

Alias
UMLS CUI [1]
C1269683
evidence of at least 6 consecutive claims for traditional antidepressant therapy with a 30 day supply or at least 2 claims with a 90 day supply (consecutive defined as ≤15 days gap)
Description

Antidepressive Agents

Data type

boolean

Alias
UMLS CUI [1]
C0003289
must be continually enrolled during the study timeframe and have both medical and pharmacy benefits
Description

Enrollment Continuous

Data type

boolean

Alias
UMLS CUI [1,1]
C1516879
UMLS CUI [1,2]
C0549178
evidence of at least 4 consecutive claims for an atypical antipsychotic prescription with a 30 day supply or 2 claims with a 90 day supply (consecutive defined as ≤15 days gap)
Description

Atypical antipsychotic

Data type

boolean

Alias
UMLS CUI [1]
C1276996
evidence of antidepressant therapy for at least 60 consecutive days prior to the initiation of atypical antipsychotic
Description

Antidepressive Agents prior to Atypical antipsychotic

Data type

boolean

Alias
UMLS CUI [1,1]
C0003289
UMLS CUI [1,2]
C0332152
UMLS CUI [1,3]
C1276996
after at least a 60 day trial of traditional antidepressant medications, patient augments with an atypical antipsychotic medication for at least 4 months.
Description

Antidepressive Agents | Atypical antipsychotic Additional

Data type

boolean

Alias
UMLS CUI [1]
C0003289
UMLS CUI [2,1]
C1276996
UMLS CUI [2,2]
C1524062
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients are excluded if they:
Description

Criteria Fulfill

Data type

boolean

Alias
UMLS CUI [1,1]
C0243161
UMLS CUI [1,2]
C1550543
have any claims for a diagnosis of schizophrenia, schizoaffective or bipolar disorder during the study period
Description

Schizophrenia | Schizoaffective Disorder | Bipolar Disorder

Data type

boolean

Alias
UMLS CUI [1]
C0036341
UMLS CUI [2]
C0036337
UMLS CUI [3]
C0005586
have electroconvulsive therapy (ect) during the study period
Description

Electroconvulsive Therapy

Data type

boolean

Alias
UMLS CUI [1]
C0013806
new augmentation with mood stabilizers, l-thyroxine (t4), l-thyronine (t3), buspirone, stimulant, or others during the post-period (table 1)
Description

Mood Stabilizer | Thyroxine | Triiodothyronine | Buspirone | Stimulant

Data type

boolean

Alias
UMLS CUI [1]
C2917435
UMLS CUI [2]
C0040165
UMLS CUI [3]
C0041014
UMLS CUI [4]
C0006462
UMLS CUI [5]
C0304402
are pregnant during the study period
Description

Pregnancy

Data type

boolean

Alias
UMLS CUI [1]
C0032961
patients with medicare or medicaid
Description

Patients Medicare | Patients Medicaid

Data type

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C0018717
UMLS CUI [2,1]
C0030705
UMLS CUI [2,2]
C0025071
Back to the top of the page

Similar models

Eligibility Depressive Disorder, Major NCT01145313

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Criteria Fulfill
Item
patients who meet the following criteria will be included in the study:
boolean
C0243161 (UMLS CUI [1,1])
C1550543 (UMLS CUI [1,2])
Age
Item
aged 18 to 64 years
boolean
C0001779 (UMLS CUI [1])
Major Depressive Disorder
Item
diagnosis of major depressive disorder during the study timeframe (icd 9 codes 296.2, 296.3, 311)
boolean
C1269683 (UMLS CUI [1])
Antidepressive Agents
Item
evidence of at least 6 consecutive claims for traditional antidepressant therapy with a 30 day supply or at least 2 claims with a 90 day supply (consecutive defined as ≤15 days gap)
boolean
C0003289 (UMLS CUI [1])
Enrollment Continuous
Item
must be continually enrolled during the study timeframe and have both medical and pharmacy benefits
boolean
C1516879 (UMLS CUI [1,1])
C0549178 (UMLS CUI [1,2])
Atypical antipsychotic
Item
evidence of at least 4 consecutive claims for an atypical antipsychotic prescription with a 30 day supply or 2 claims with a 90 day supply (consecutive defined as ≤15 days gap)
boolean
C1276996 (UMLS CUI [1])
Antidepressive Agents prior to Atypical antipsychotic
Item
evidence of antidepressant therapy for at least 60 consecutive days prior to the initiation of atypical antipsychotic
boolean
C0003289 (UMLS CUI [1,1])
C0332152 (UMLS CUI [1,2])
C1276996 (UMLS CUI [1,3])
Antidepressive Agents | Atypical antipsychotic Additional
Item
after at least a 60 day trial of traditional antidepressant medications, patient augments with an atypical antipsychotic medication for at least 4 months.
boolean
C0003289 (UMLS CUI [1])
C1276996 (UMLS CUI [2,1])
C1524062 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
Criteria Fulfill
Item
patients are excluded if they:
boolean
C0243161 (UMLS CUI [1,1])
C1550543 (UMLS CUI [1,2])
Schizophrenia | Schizoaffective Disorder | Bipolar Disorder
Item
have any claims for a diagnosis of schizophrenia, schizoaffective or bipolar disorder during the study period
boolean
C0036341 (UMLS CUI [1])
C0036337 (UMLS CUI [2])
C0005586 (UMLS CUI [3])
Electroconvulsive Therapy
Item
have electroconvulsive therapy (ect) during the study period
boolean
C0013806 (UMLS CUI [1])
Mood Stabilizer | Thyroxine | Triiodothyronine | Buspirone | Stimulant
Item
new augmentation with mood stabilizers, l-thyroxine (t4), l-thyronine (t3), buspirone, stimulant, or others during the post-period (table 1)
boolean
C2917435 (UMLS CUI [1])
C0040165 (UMLS CUI [2])
C0041014 (UMLS CUI [3])
C0006462 (UMLS CUI [4])
C0304402 (UMLS CUI [5])
Pregnancy
Item
are pregnant during the study period
boolean
C0032961 (UMLS CUI [1])
Patients Medicare | Patients Medicaid
Item
patients with medicare or medicaid
boolean
C0030705 (UMLS CUI [1,1])
C0018717 (UMLS CUI [1,2])
C0030705 (UMLS CUI [2,1])
C0025071 (UMLS CUI [2,2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial